KPV Peptide: The Alpha-MSH Fragment Researchers Are Watching for Gut & Immune Signaling

What Is KPV?

KPV (Lys-Pro-Val) is a naturally derived tripeptide composed of lysine, proline, and valine — corresponding to the C-terminal sequence of alpha-melanocyte-stimulating hormone (α-MSH). While α-MSH is well established in immunomodulatory research, KPV has emerged as a compelling standalone subject due to its ability to interact with inflammatory signaling pathways independently of the full parent peptide. Its small size, stability, and receptor selectivity make it a practical and increasingly studied compound in preclinical research.

Mechanism of Interest in Research

KPV's primary area of investigation centers on its interaction with melanocortin receptors (MC1R and MC3R) and downstream modulation of pro-inflammatory cytokine cascades. In preclinical models, KPV has been studied for its ability to suppress NF-κB signaling — a master regulator of inflammatory gene expression — and reduce the production of cytokines including IL-1β, IL-6, and TNF-α. Notably, research suggests KPV can exert these effects both systemically and at the local tissue level, making it relevant across multiple experimental contexts.

Gut Biology and Intestinal Inflammation Research

One of the most active areas of KPV investigation involves intestinal inflammation and gut barrier integrity. Preclinical studies have examined KPV in models of colitis and inflammatory bowel conditions, with findings suggesting the peptide may reduce mucosal inflammation, support epithelial barrier function, and modulate immune cell activity within the gut environment. Researchers have noted particular interest in KPV's ability to reach intestinal tissue effectively due to its resistance to enzymatic degradation — a property that distinguishes it from larger peptide compounds in gastrointestinal research models.

Key Areas of Experimental Investigation

• NF-κB and cytokine suppression — Studies examining KPV's ability to downregulate pro-inflammatory signaling cascades in immune cell and epithelial models
• Intestinal inflammation models — Preclinical colitis research exploring KPV's effects on mucosal integrity and inflammatory immune responses
• Melanocortin receptor signaling — Investigation of MC1R and MC3R pathway activation and downstream anti-inflammatory outcomes
• Wound healing and tissue repair — Early research into KPV's role in skin and mucosal repair processes mediated by immune modulation
• Gut-immune axis — Models studying the relationship between intestinal peptide signaling and systemic inflammatory tone

Research Compound Specifications

Parameter	Specification
Full Name	Lysine-Proline-Valine (KPV)
Derived From	C-terminal sequence of α-MSH
Compound Class	Tripeptide / melanocortin fragment
Primary Research Target	NF-κB signaling, melanocortin receptors, cytokine modulation
Form	Lyophilized powder
Purity	≥98% (HPLC verified)
Storage	−20°C, protect from light and moisture
Application	Research use only — not for human or veterinary use

KPV is supplied strictly as a research compound for laboratory and scientific investigation only. Not approved for human consumption, clinical application, or diagnostic purposes. All experimentation should be conducted by qualified professionals in appropriate research settings.